Skip to main content

Boehringer Ingelheim

Boehringer Ingelheim

Type

Investor

Founded

1885

Funding Rounds

7

Portfolio companies

7

About Boehringer Ingelheim

Boehringer Ingelheim is a leading research-driven, family-owned biopharmaceutical company focused on discovering, developing, manufacturing, and marketing innovative medicines for humans and animals, operating in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing, with key areas including heart/metabolic, respiratory, oncology, and mental health, aiming to transform lives through long-term innovation.

Boehringer Ingelheim investments captured (7)

Company NameStageTotal Deal AmountDate
MedikeaMedikeaPre-Seed$1.2mOct 26, 2026
***********undisclosedOct 13, 2026
***********undisclosedOct 13, 2026
**********************Dec 10, 2025
**********************Dec 10, 2025